Skip to content

Lactate Use as Triage Tool in Sepsis : Veinous, Capillary or Arterial?

Lactate and Sepsis : What Dosage Use as Triage Tool in Emergency Department for Patients With Suspected Infection.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01964690
Enrollment
103
Registered
2013-10-17
Start date
2013-12-31
Completion date
2014-04-30
Last updated
2014-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

Lactate, Sepsis, Capillary lactate, Venous lactate, Quick test

Brief summary

Severe sepsis and septic shocks are increasingly codified. A biomarker as Lactate is very interesting to detect those situations. Usually, lactate used is arterial but results are often too slow to obtain if we want to respect Surviving Sepsis Campaign guidelines. Some analyzers (EKF diagnostics Lactate Scout\*) can give results in 15 seconds. We hypothesized that capillary lactate, easy to sample, tested with this analyzer may detect earlier those infections states and we want to find the most accurate site to detect severe sepsis (capillary, venous or arterial sample).

Detailed description

Actually, patients presenting a sepsis with arterial lactate\> 2 mmol.l-1 must be considered as criticals, and if lactate\> 4 mmol.l-1 as septic shock. However, results are usually slow to obtain, especially if we want to respect the Surving Sepsis Campaign, which preconize antibiotic as soon as possible (first hour). In admission room, arterial sample can't be easily done and usual results need more than 30 minutes. On the contrary, using analyzers like EKF diagnostics Lactate Scout\* can give results faster with capillary blood (15 seconds). We will compare this results with both veinous and arterial lactate. * For primary outcome, we will determine the most accurate value of capillary or veinous lactate that may be able to detect critical patient suspected of infection. * for secondary outcomes, we will determine if quick capillary lactate test may replace arterial lactate in this indication and be able to predict mortality.

Interventions

None listed

Sponsors

Hopital Saint Roch
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 years * S.I.R.S : 2 or more criteria (fever \> 38.3°C or hypothermia (core temperature \< 36°C) heart rate \> 90.min-1, tachypnea, altered mental status) * Suspected infection

Exclusion criteria

* Arterial sample by laboratory reference method no available

Design outcomes

Primary

MeasureTime frameDescription
Lactate valueAt admission in emergency departmentDetermine the most accurate value of capillary or venous lactate that may be able to early detect patients with severe sepsis or septic shock, using quick test (EKF diagnostics Lactate scout\*).

Secondary

MeasureTime frameDescription
Comparison values of capillary lactate and arterial lactate30 minutes after samplingDetermine if capillary blood lactate may replace laboratory reference method (arterial lactate)
MortalityDay 28 mortalityDetermine if capillary lactate value can be use as a mortality predictive tool

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026